RE: Rydzewska et al. Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis. Eur J Cancer. 2017 Oct; 84:88–101

Christopher J.D. Wallis, Zachary W A Klaassen

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)216-217
Number of pages2
JournalEuropean Journal of Cancer
Volume94
DOIs
StatePublished - May 1 2018
Externally publishedYes

Fingerprint

Androgens
Meta-Analysis
Prostatic Neoplasms
Hormones
Neoplasms
Therapeutics
abiraterone

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

@article{14dc8f1d46b546b99ddb926cedc7fa18,
title = "RE: Rydzewska et al. Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis. Eur J Cancer. 2017 Oct; 84:88–101",
author = "Wallis, {Christopher J.D.} and Klaassen, {Zachary W A}",
year = "2018",
month = "5",
day = "1",
doi = "10.1016/j.ejca.2018.01.115",
language = "English (US)",
volume = "94",
pages = "216--217",
journal = "European Journal of Cancer",
issn = "0959-8049",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - RE

T2 - Rydzewska et al. Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis. Eur J Cancer. 2017 Oct; 84:88–101

AU - Wallis, Christopher J.D.

AU - Klaassen, Zachary W A

PY - 2018/5/1

Y1 - 2018/5/1

UR - http://www.scopus.com/inward/record.url?scp=85045061851&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045061851&partnerID=8YFLogxK

U2 - 10.1016/j.ejca.2018.01.115

DO - 10.1016/j.ejca.2018.01.115

M3 - Letter

C2 - 29573942

AN - SCOPUS:85045061851

VL - 94

SP - 216

EP - 217

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

ER -